Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
iRadimed Corporation - Common Stock
(NQ:
IRMD
)
51.77
-0.19 (-0.37%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about iRadimed Corporation - Common Stock
< Previous
1
2
3
Next >
Intuitive Surgical Gets Rating Upgrade. No. 1 In Its Industry; Profits, Sales Climbing.
April 09, 2025
Intuitive Surgical, No. 1 stock in its group, has a deep moat around its technology and has sold is robotic surgical systems for 30 years.
Via
Investor's Business Daily
Topics
Initial Public Offering
Exposures
Securities Market
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
March 10, 2025
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
February 13, 2025
From
iRadimed Corporation
Via
GlobeNewswire
Earnings Scheduled For February 13, 2025
February 13, 2025
Via
Benzinga
Should you consider IRADIMED CORP (NASDAQ:IRMD) for quality investing?
February 11, 2025
A fundamental analysis of (NASDAQ:IRMD): Why IRADIMED CORP (NASDAQ:IRMD) qualifies as a quality stock.
Via
Chartmill
Exploring NASDAQ:IRMD's quality characteristics.
December 31, 2024
Reasonable growth and debt and a high ROIC for IRADIMED CORP (NASDAQ:IRMD).
Via
Chartmill
Earnings Scheduled For February 8, 2024
February 08, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via
Benzinga
iRadimed's Earnings Outlook
February 07, 2024
Via
Benzinga
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
January 30, 2025
From
iRadimed Corporation
Via
GlobeNewswire
Reasonable Growth, Debt Levels, and a High ROIC Make IRADIMED CORP (NASDAQ:IRMD) Appealing to Quality Investors.
January 21, 2025
Why the quality investor may take a look at IRADIMED CORP (NASDAQ:IRMD).
Via
Chartmill
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
January 10, 2025
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025
December 10, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
November 04, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
October 31, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
October 24, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
October 03, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Masimo Stock Gets Relative Strength Rating Upgrade
October 01, 2024
The Relative Strength Rating for Masimo stock jumped into a higher percentile Tuesday, as it got a lift from 69 to 78.
Via
Investor's Business Daily
Lytham Partners Announces KOL Panels and Participating Companies for its Fall 2024 Investor Conference
September 30, 2024
Phoenix, Arizona and New York, New York--(Newsfile Corp. - September 30, 2024) - Lytham...
Via
Newsfile
IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference
September 10, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
August 01, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
July 25, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
June 07, 2024
Trading to commence effective on the market open June 14, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRMD Stock Earnings: iRadimed Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
IRMD stock results show that iRadimed beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
May 02, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
April 25, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
March 13, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
February 08, 2024
From
iRadimed Corporation
Via
GlobeNewswire
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
February 01, 2024
From
iRadimed Corporation
Via
GlobeNewswire
Bruker Stock Rising, Near Buy Point; Gets Rating Upgrade
January 30, 2024
A Relative Strength Rating upgrade for Bruker stock shows improving technical performance. Will it continue?
Via
Investor's Business Daily
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.